Skip to content

XENE XENON PHARMACEUTICALS INC

Follow

Stock (common), issuer CIK 1582313

208 managers (210 13F filers) reported a position in XENE shares at 2024-12-31, 76,301,942 shares in all. 23 filers opened a position and 21 filers sold out during the quarter.

Managers
208
13F filers
210
New
23
Added
66
Reduced
69
Sold out
21
Shares held by filers
76,301,942

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2024

Filers in the available 13F reports with a share position at 2024-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
EverSource Wealth Advisors, LLCin group EverSource Wealth Advisors, L…30$1.18K<0.01%-38813F-HRTimelineGroup
RHUMBLINE ADVISERS29$1.14K<0.01%013F-HR/ATimeline
Continuum Advisory, LLC27$1.06K<0.01%013F-HRTimeline
Allworth Financial LP12$471<0.01%013F-HRTimeline
J.Safra Asset Management Corp11$424<0.01%013F-HRTimeline
C M BIDWELL & ASSOCIATES LTD9$353<0.01%013F-HRTimeline
Hexagon Capital Partners LLC6$235<0.01%new13F-HRTimeline
NOMURA ASSET MANAGEMENT CO LTDin group NOMURA ASSET MANAGEMENT CO LTD0$00%013F-HRTimelineGroupValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.